ClearPoint Neuro's system enables precise delivery to the seizure focus, ensuring best possible efficacy and safety of EpilepsyGTx's investigational gene therap...

·        Three-part event series will comprise a digital forum (30th September 2026), and two in-person events (Lond...

Internationally recognised business executive with extensive operational experience in life sciences, diagnostics and pharma Appointment will lead strategic ...

Strengthens ECI's AI & Digital Transformation capabilities to help clients develop the next generation of software-enabled medical technologies  Enhan...

·       Strengthens multiomics portfolio offering metabolite-level insight to connect molecular data with biological function ...

New research team expands capabilities at Boehringer's U.S. R&D site in Ridgefield, Connecticut. Leverages human retina models to enable more predictive,...

The burden of diagnosed prevalent cases of chronic hepatitis C in the 8MM* is expected to increase at an annual growth rate (AGR) of 0.40 from 7.19 million in 20...

Since the FDA first awarded a regenerative medicine advanced therapeutic (RMAT) designation in 2017, activity in this space remained relatively modest until 2023...

Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, and EpiCypher®, the leading provider of ChIC/CUT&RUN technology, ...

New Vericheck ddPCR™ Kits Combine Highly Specific and Highly Sensitive DNA Detection and Quantification with the QX700™ System's Seven-Color Multiplexing, Simpli...